title: Granulomatous foreign-body reaction with facial dermal fillers after omalizumab treatment for severe persistent allergic asthma: a case report.
authors.forename: A
authors.initials: A
authors.lastname: Dammak
authors.forename: C
authors.initials: C
authors.lastname: Taillé
authors.forename: E
authors.initials: E
authors.lastname: Marinho
authors.forename: B
authors.initials: B
authors.lastname: Crestani
authors.forename: B
authors.initials: B
authors.lastname: Crickx
authors.forename: V
authors.initials: V
authors.lastname: Descamps
mesh_terms: D018927:Anti-Asthmatic Agents / Q000009:adverse effects*; D000888:Antibodies, Anti-Idiotypic / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects*; D001249:Asthma / Q000188:drug therapy*; D002908:Chronic Disease; D003357:Cosmetic Techniques; D017886:Durapatite / Q000009:adverse effects; D005148:Facial Dermatoses / Q000139:chemically induced*; D005260:Female; D005549:Foreign-Body Reaction / Q000139:chemically induced*; D006801:Humans; D006820:Hyaluronic Acid / Q000009:adverse effects; D008875:Middle Aged; D000069444:Omalizumab; D055675:Viscosupplements / Q000009:adverse effects
chemical_list: D018927:Anti-Asthmatic Agents; D000888:Antibodies, Anti-Idiotypic; D061067:Antibodies, Monoclonal, Humanized; D055675:Viscosupplements; D000069444:Omalizumab; D006820:Hyaluronic Acid; D017886:Durapatite